Novartis

News

Janssen J&J Johnson and Johnson pharmaceutical companies

New data sets up potential new gastro use for J&J's Stelara

Janssen’s Stelara has shown positive results in an ulcerative colitis (UC) trial, setting up a potential new indication for the inflammatory diseases drug.

Partner Content

Partner Content

An Interview with Alexander Zuern, Device Testing Manager, f...

Pre-Filled Syringes & Injectable Drug Devices Europe

News

Novartis chases untapped MS market with siponimod

US and European regulators have accepted filings for Novartis’s siponimod for secondary progressive multiple sclerosis (SPMS).

News

Lilly's breast cancer drug Verzenio approved in EU

Eli Lilly’s Verzenio breast cancer drug has been approved in Europe, as the pharma prepares to compete with established rivals from Pfizer and Novartis.

News

Roche aims to extend shelf life of Xolair with new prefilled...

The FDA has approved a new prefilled syringe formulation for Roche’s asthma drug Xolair, as the Swiss company aims to prolong its shelf life.

News

Lilly pushes into migraine market as Emgality approved in US

The FDA has approved Eli Lilly’s Emgality (galcanezumab) for migraine prevention in adults, the third in a group of new class of drugs for the condition.

New data sets up potential new gastro use for J&J's Stelara

An Interview with Alexander Zuern, Device Testing Manager, f...

Novartis chases untapped MS market with siponimod

Lilly's breast cancer drug Verzenio approved in EU

Roche aims to extend shelf life of Xolair with new prefilled...

Lilly pushes into migraine market as Emgality approved in US

Australia starts probe into AI infiltration of Medicare

Discover a new era of healthcare panel engagement: Grounded ...

Novartis

Editor's Picks